Thromboelastography Market to Flourish due to Increasing Target Disease Prevalence

Thromboelastography Market


The Thromboelastography Market is estimated to be valued at US$ 604.07 Mn in 2022 and is expected to exhibit a CAGR of 7.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market Overview:
Thromboelastography (TEG) is increasingly being used in clinical practice for hemostasis testing and monitoring. It provides insights into the entire coagulation process including clot formation, strength, and breakdown. TEG finds applications in cardiothoracic surgery, liver transplantations, and assessment of bleeding risks.

Market Dynamics:
The market is driven by the rising prevalence of cardiovascular diseases and trauma cases worldwide. As per the World Health Organization, cardiovascular diseases are the leading cause of death globally, taking an estimated 17.9 million lives each year. TEG aids in effective management of blood coagulation in such high-risk patients. Moreover, technological advancements in TEG devices toward miniaturization, automation, and real-time evaluation are expanding their utilization in clinical research. Several manufacturers are focusing on developing TEG analyzers integrated with artificial intelligence for improved diagnostics.

Market key trends:
The thromboelastography market is witnessing significant growth due to the increasing demand for point-of-care coagulation testing. TEG helps in comprehensive assessment of hemostasis and reveals abnormalities that are not detected by conventional tests. It assists clinicians in efficient treatment and management of bleeding and thrombosis. The growing number of surgical procedures along with rising prevalence of cardiac diseases and blood disorders is expected to propel the demand for thromboelastography over the forecast period.

SWOT Analysis
Strengths: TEG provides real-time, whole-blood analysis of coagulation, which assists physicians in quick diagnosis and treatment. It also reduces turnaround times compared to conventional coagulation tests.
Weaknesses: High cost of TEG analyzers limits their adoption in resource-constrained settings. Lack of standardization in result interpretation is also a challenge.
Opportunities: Growing number of trauma cases and rising spending on healthcare infrastructure in developing nations can present lucrative opportunities. Expansion in clinical applications of TEG also offers scope for market growth.
Threats: Strong competition from alternative coagulation monitoring technologies can threaten market share of TEG. Longer reimbursement policies also restrict market expansion.

Key Takeaways
The Global Thromboelastography Market Size is expected to witness high growth, exhibiting CAGR of 7.1% over the forecast period, due to increasing number of surgical procedures. The US dominated the global market in 2022, with a share of over 30% owing to presence of advanced healthcare facilities and favorable reimbursement policies.

Regional analysis
North America is expected to remain the leading regional market during the forecast period, supported by robust healthcare infrastructure and rising geriatric population. Europe is anticipated to grow lucratively, with key contributors being Germany, UK, and France. Asia Pacific exhibits lucrative prospects, with China and India emerging as high potential countries due to improving access to healthcare and diagnostic services.

Key players
Key players operating in the thromboelastography market include Lepu Medical Technology (Beijing) Co.,Ltd., Render Biotech Co., Haemonetics Corporation, TA Instruments, HemaCore LLC, 5-Diagnostics, Xenometrix AG, Framar Hemologix srl, Instrumentation Laboratory, Medirox AB, Diagnostica Stago, Life Diagnostica, SYCOmed e.K., Nordic Biomarket, and Shenzhen Ultra-Diagnostics Biotec. Co., Ltd. The market demonstrates a moderate level of consolidation with top players accounting for over 60% share. 

Comments

Post a Comment

Popular posts from this blog

Electric Wheelchair Market Size, Share, Outlook, and Opportunity Analysis, 2021 – 2028

Image
  Electric Wheelchair A wheelchair is used to help those who are unable to walk due to disease, accident, or disability. Manual wheelchairs and power or electric wheelchairs are the two types of wheelchairs available. A wheelchair is used for mobility by a disabled person or someone who is unable to walk due to an injury or illness. They are suitable for both outdoor and indoor use. Electric Wheelchairs that are customised for everyday usage or specialised to a certain field activity are also available. Wheelchairs reduce the user's issues or suffering, such as back pain, sores, digestion, and breathing. Those with upper body strength often use manual wheelchairs, whereas patients who are fatigued typically utilise electric wheelchairs. According to Coherent Market Insights, The global Electric Wheelchair Market is estimated to be valued at US$ 6,387.3 Mn in 2021, and is expected to exhibit a CAGR of 10.7% over the forecast period (2021-2028). Automated movement systems have ...
Read more

The Global Benzocaine Market Size Is Expected To Exhibit A Cagr Of 2.70% Over The Forecast Period (2020-2027).

Image
  Benzocaine, also known as americaine or anaesthesin, is an organic compound that belongs to the benzoic acid esters class. Benzocaine is a pharmaceutical active ingredient with a variety of medicinal properties. It is used to treat sexual disorders like premature ejaculation, as a topical anaesthetic in diseases like mouth and esophageal ulcers, as a pain reliever in dental diseases like tooth decay and dental caries, and to treat skin irritation like vaginal irritation in females. Benzocaine API is a solid physical substance that is slightly soluble in water and has the chemical name Ethyl 4-aminobenzoate.   The global benzocaine market size is estimated to be valued at US$ 128.9 million in 2020 and is expected to exhibit a CAGR of 2.70% over the forecast period (2020-2027). Benzocaine is an effective numbing agent that is used prior to surgical procedures. It prevents nerve signals from reaching the brain from a specific part of the body. It is classified as a local anaest...
Read more

Ginseng Market Outlook, Analysis and forecast up to 2028

Image
  Ginseng Market Ginseng is a slow-growing perennial plant with green oval-shaped leaves and meaty roots that can persist for more than a century. Ginseng is classified into two types: American ginseng and Asian ginseng. Panax quinquefolius is the scientific name for American ginseng, whereas Panax ginseng is the scientific name for Asian ginseng. Ginseng is widely used as a herb to increase the body's energy levels. Ginseng's antioxidant and anti-inflammatory qualities serve to enhance the immune system, lowering the risk of viral and microbial infections. Ginseng also helps to lower the risk of diseases such as lung cancer, skin cancer, and liver cancer. Other health advantages of ginseng include lower blood sugar levels and improved cognitive functions such as memory and conduct. Ginseng is mostly grown in the United States, Canada, and South Korea. Ginseng has been used as a herbal medicine in China for generations, and the country is one of its largest users. Asia Pacifi...
Read more